Clinical Trial Update: The Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal Polyps [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating CM310 for chronic rhinosinusitis with nasal polyps has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• CM310

Snippet

Sponsor: Keymed Biosciences Co.Ltd | Conditions: Chronic Rhinosinusitis With Nasal Polyps | Phase 2 | Status: COMPLETED